J&J Unit Launches 6th Challenge To Drug Price Negotiations
Johnson & Johnson unit Janssen Pharmaceuticals has launched a suit to challenge a system allowing Medicare to negotiate prescription drug prices under a federal inflation deterrent, marking at least the sixth...To view the full article, register now.
Already a subscriber? Click here to view full article